217 related articles for article (PubMed ID: 30911516)
1. Prolactin and thyroid stimulating hormone affecting the pattern of LH/FSH secretion in patients with polycystic ovary syndrome: A hospital-based study from North East India.
Nath CK; Barman B; Das A; Rajkhowa P; Baruah P; Baruah M; Baruah A
J Family Med Prim Care; 2019 Jan; 8(1):256-260. PubMed ID: 30911516
[TBL] [Abstract][Full Text] [Related]
2. Follicle Stimulating Hormone (LH: FSH) Ratio in Polycystic Ovary Syndrome (PCOS) - Obese vs. Non- Obese Women.
Saadia Z
Med Arch; 2020 Aug; 74(4):289-293. PubMed ID: 33041447
[TBL] [Abstract][Full Text] [Related]
3. Incidence of elevated LH/FSH ratio in polycystic ovary syndrome women with normo- and hyperinsulinemia.
Banaszewska B; Spaczyński RZ; Pelesz M; Pawelczyk L
Rocz Akad Med Bialymst; 2003; 48():131-4. PubMed ID: 14737959
[TBL] [Abstract][Full Text] [Related]
4. Elevated serum levels of anti-Müllerian hormone can be introduced as a new diagnostic marker for polycystic ovary syndrome.
Sahmay S; Atakul N; Aydogan B; Aydin Y; Imamoglu M; Seyisoglu H
Acta Obstet Gynecol Scand; 2013 Dec; 92(12):1369-74. PubMed ID: 23980726
[TBL] [Abstract][Full Text] [Related]
5. Metabolic and Endocrine Characteristics of Indian Women with Polycystic Ovary Syndrome.
Kumar AN; Naidu JN; Satyanarayana U; Ramalingam K; Anitha M
Int J Fertil Steril; 2016; 10(1):22-8. PubMed ID: 27123196
[TBL] [Abstract][Full Text] [Related]
6. Compatible cut-off values for luteinizing hormone and the luteinizing hormone/follicle-stimulating hormone ratio in diagnostic criteria of the Japan Society of Obstetrics and Gynecology for polycystic ovary syndrome.
Yanagihara R; Matsuzaki T; Aoki H; Tamura K; Nagashima M; Minato S; Kamada S; Yamamoto Y; Irahara M; Iwasa T
J Obstet Gynaecol Res; 2023 Jan; 49(1):253-264. PubMed ID: 36307043
[TBL] [Abstract][Full Text] [Related]
7. [Preliminary study on the value of ratio of serum luteinizing hormone/follicle-stimulating hormone in diagnosis of polycystic ovarian syndrome among women with polycystic ovary].
Ma CS; Lin Y; Zhang CH; Xu H; Li YF; Zhang SC; Tan Y; Quan S; Xing FQ
Zhonghua Fu Chan Ke Za Zhi; 2011 Mar; 46(3):177-80. PubMed ID: 21575449
[TBL] [Abstract][Full Text] [Related]
8. Determinants of abnormal gonadotropin secretion in clinically defined women with polycystic ovary syndrome.
Taylor AE; McCourt B; Martin KA; Anderson EJ; Adams JM; Schoenfeld D; Hall JE
J Clin Endocrinol Metab; 1997 Jul; 82(7):2248-56. PubMed ID: 9215302
[TBL] [Abstract][Full Text] [Related]
9. Association of Luteinizing hormone and LH receptor gene polymorphism with susceptibility of Polycystic ovary syndrome.
Deswal R; Nanda S; Dang AS
Syst Biol Reprod Med; 2019 Oct; 65(5):400-408. PubMed ID: 30958034
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic Performance of Anti-Müllerian Hormone, Luteinizing Hormone to Follicle-Stimulating Hormone Ratio, Testosterone, and Prolactin to Predict Polycystic Ovary Syndrome Among Sudanese Women.
Alhassan S; Elmugadam A; Elfadil GA; Abubaker N; Elfaki EM; Hamza A; Abdalhabib EK; Karar T
Int J Womens Health; 2023; 15():837-843. PubMed ID: 37275514
[TBL] [Abstract][Full Text] [Related]
11. Influence of Vitamin D on the Incidence of Metabolic Syndrome and Hormonal Balance in Patients with Polycystic Ovary Syndrome.
Lejman-Larysz K; Golara A; Baranowska M; Kozłowski M; Guzik P; Szydłowska I; Nawrocka-Rutkowska J; Sowińska-Przepiera E; Cymbaluk-Płoska A; Brodowska A
Nutrients; 2023 Jun; 15(13):. PubMed ID: 37447279
[TBL] [Abstract][Full Text] [Related]
12. Inappropriate gonadotropin secretion in polycystic ovary syndrome.
Hsu MI; Liou TH; Liang SJ; Su HW; Wu CH; Hsu CS
Fertil Steril; 2009 Apr; 91(4):1168-74. PubMed ID: 18325508
[TBL] [Abstract][Full Text] [Related]
13. The prognostic value of basal luteinizing hormone:follicle-stimulating hormone ratio in the treatment of patients with polycystic ovarian syndrome by assisted reproduction techniques.
Tarlatzis BC; Grimbizis G; Pournaropoulos F; Bontis J; Lagos S; Spanos E; Mantalenakis S
Hum Reprod; 1995 Oct; 10(10):2545-9. PubMed ID: 8567767
[TBL] [Abstract][Full Text] [Related]
14. Serum luteinizing hormone level and luteinizing hormone/follicle-stimulating hormone ratio but not serum anti-Müllerian hormone level is related to ovarian volume in Korean women with polycystic ovary syndrome.
Chun S
Clin Exp Reprod Med; 2014 Jun; 41(2):86-91. PubMed ID: 25045633
[TBL] [Abstract][Full Text] [Related]
15. The Relevant Hormonal Levels and Diagnostic Features of Polycystic Ovary Syndrome in Adolescents.
Khashchenko E; Uvarova E; Vysokikh M; Ivanets T; Krechetova L; Tarasova N; Sukhanova I; Mamedova F; Borovikov P; Balashov I; Sukhikh G
J Clin Med; 2020 Jun; 9(6):. PubMed ID: 32545404
[TBL] [Abstract][Full Text] [Related]
16. Free testosterone, luteinizing hormone/follicle stimulating hormone ratio and pelvic sonography in relation to skin manifestations in patients with polycystic ovary syndrome.
Sharquie KE; Al-Bayatti AA; Al-Ajeel AI; Al-Bahar AJ; Al-Nuaimy AA
Saudi Med J; 2007 Jul; 28(7):1039-43. PubMed ID: 17603706
[TBL] [Abstract][Full Text] [Related]
17. [Clinical features, hormonal profile, and metabolic abnormalities of obese women with obese polycystic ovary syndrome].
Li X; Lin JF
Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(46):3266-71. PubMed ID: 16409817
[TBL] [Abstract][Full Text] [Related]
18. [Serum levels of anti-muller hormone in women with polycystic ovary syndrome and healthy women of reproductive age].
Parahuleva N; Pehlivanov B; Orbecova M; Deneva T; Uchikova E
Akush Ginekol (Sofiia); 2013; 52 Suppl 1():16-23. PubMed ID: 24294740
[TBL] [Abstract][Full Text] [Related]
19. A study of hormonal and anthropometric parameters in polycystic ovarian syndrome.
Kambale T; Sawaimul KD; Prakash S
Ann Afr Med; 2023; 22(1):112-116. PubMed ID: 36695232
[TBL] [Abstract][Full Text] [Related]
20. Endocrine changes after laparoscopic ovarian drilling in clomiphene citrate-resistant women with polycystic ovarian syndrome.
Al-Ojaimi EH
Saudi Med J; 2004 Aug; 25(8):1032-9. PubMed ID: 15322594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
